We are live on ! Find out more
ITP

Iron Triangle Partners Portfolio holdings

AUM $875M
1-Year Est. Return 49.85%
This Fund
S&P 500
This Quarter Est. Return
+3.47%
1 Year Est. Return
+49.85%
3 Year Est. Return
+151.9%
5 Year Est. Return
+239.84%
10 Year Est. Return
–
AUM
$718M
AUM Growth
+$20.9M
Cap. Flow
+$1.92M
Cap. Flow %
0.27%
Top 10 Hldgs %
54.68%
Holding
33
New
7
Increased
8
Reduced
9
Closed
8

Top Buys

Rank Stock Value
1
DVA icon
DaVita
DVA
+$48.4M
2
NSTG
NanoString Technologies, Inc.
NSTG
+$32.8M
3
UNH icon
UnitedHealth
UNH
+$27.2M
4
ICUI icon
ICU Medical
ICUI
+$26.7M
5
GH icon
Guardant Health
GH
+$25.9M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$61.3M
2
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$36.8M
3
HCA icon
HCA Healthcare
HCA
+$23.6M
4
HOLX
Hologic
HOLX
+$23.5M
5
BSX icon
Boston Scientific
BSX
+$21.7M

Sector Composition

Rank Sector Weight
1 Healthcare 98.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DVA icon
1
DaVita
DVA
$15.2B
$51.2M 7.13%
+450,000
New +$48.4M
NVST icon
2
Envista
NVST
$4.34B
$47.8M 6.66%
1,060,000
-408,787
-28% -$16.8M
GH icon
3
Guardant Health
GH
$19.3B
$44M 6.14%
440,255
+250,255
+132% +$25.9M
CTLT
4
DELISTED
CATALENT, INC.
CTLT
$40.5M 5.65%
316,661
+56,661
+22% +$7.28M
ACHC icon
5
Acadia Healthcare
ACHC
$2.99B
$38.4M 5.35%
632,189
+311,189
+97% +$18.6M
UTHR icon
6
United Therapeutics
UTHR
$26.3B
$36.7M 5.12%
170,000
+100,000
+143% +$19.6M
NVRO
7
DELISTED
NEVRO CORP.
NVRO
$34.2M 4.77%
422,260
+18,836
+5% +$1.89M
ICLR icon
8
Icon
ICLR
$13B
$34.1M 4.75%
110,000
-20,000
-15% -$5.6M
ABBV icon
9
AbbVie
ABBV
$454B
$33.9M 4.72%
250,000
-143,024
-36% -$16.9M
NSTG
10
DELISTED
NanoString Technologies, Inc.
NSTG
$31.7M 4.41%
+750,000
New +$32.8M
MOH icon
11
Molina Healthcare
MOH
$10.4B
$31.1M 4.34%
97,893
-12,968
-12% -$3.86M
UNH icon
12
UnitedHealth
UNH
$379B
$30.1M 4.2%
+60,000
New +$27.2M
SGRY icon
13
Surgery Partners
SGRY
$1.98B
$29M 4.05%
+543,696
New +$25.2M
ICUI icon
14
ICU Medical
ICUI
$4.04B
$27.2M 3.79%
+114,506
New +$26.7M
CRL icon
15
Charles River Laboratories
CRL
$10.8B
$26.4M 3.68%
70,000
+32,596
+87% +$12.7M
ALGN icon
16
Align Technology
ALGN
$12B
$26.3M 3.66%
40,000
+5,000
+14% +$3.21M
HZNP
17
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$25.6M 3.57%
237,470
-336,997
-59% -$36.8M
HOLX
18
DELISTED
Hologic
HOLX
$21.4M 2.99%
280,000
-320,000
-53% -$23.5M
CNMD icon
19
CONMED
CNMD
$1.31B
$21.2M 2.96%
149,777
-40,223
-21% -$5.7M
AHCO icon
20
AdaptHealth
AHCO
$1.49B
$17.1M 2.39%
+700,000
New +$16.4M
SLGC
21
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
$16.7M 2.33%
1,437,246
+1,118,584
+351% +$13.4M
TMO icon
22
Thermo Fisher Scientific
TMO
$208B
$16M 2.23%
24,000
-11,000
-31% -$6.87M
LH icon
23
Labcorp
LH
$24.7B
$15.7M 2.19%
+58,200
New +$14.4M
STXS icon
24
Stereotaxis
STXS
$130M
$11.3M 1.58%
1,826,728
-166,306
-8% -$994K
OHPAU
25
DELISTED
Orion Acquisition Corp. Unit
OHPAU
$9.91M 1.38%
1,006,229
– –
1
2

Similar funds

8KM
8 Knots Management Dallas, Texas $868M AUM 30.97% 1-Year Est. Return
MFG
MidWestOne Financial Group Iowa City, Iowa $900M AUM 23.95% 1-Year Est. Return
NP
Ninepoint Partners Toronto, Ontario, Canada $904M AUM 39.64% 1-Year Est. Return
GGI
Galaxy Group Investments New York $843M AUM 47.48% 1-Year Est. Return
WFAL
Wedbush Fund Advisers, LLC Pasadena, California $967M AUM
OBWP
O'Brien Wealth Partners Waltham, Massachusetts $756M AUM 13.93% 1-Year Est. Return
TWM
Tolleson Wealth Management Dallas, Texas $693M AUM 17.6% 1-Year Est. Return
AGC
Angelo Gordon & Co New York $1.06B AUM 47.95% 1-Year Est. Return

Iron Triangle Partners's Q4 2021 Portfolio in Review

As of Q4 2021, Iron Triangle Partners held 33 positions worth $718M, up 3% from $697M the previous quarter. Its ten largest holdings account for 55% of the portfolio.

Iron Triangle Partners's Q4 2021 filing shows 7 new, 8 increased, 9 reduced and 8 closed positions. Its largest new stake was DaVita: 450,000 shares worth $51.2M. The largest sale was Humana, an estimated $61.3M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 99% a quarter earlier.

  • Iron Triangle Partners's largest Q4 2021 buy was DaVita: 450,000 shares worth $51.2M.
  • Iron Triangle Partners added most to Guardant Health in Q4 2021, an estimated $25.9M increase.
  • Iron Triangle Partners's biggest Q4 2021 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $36.8M.
  • Iron Triangle Partners fully exited Humana in Q4 2021, selling an estimated $61.3M.
  • Iron Triangle Partners's ten largest holdings make up 55% of its $718M portfolio in Q4 2021.
  • Iron Triangle Partners opened 7 new positions and closed 8 in Q4 2021.
  • Iron Triangle Partners's portfolio value rose 3% quarter-over-quarter to $718M.

Based on Iron Triangle Partners's 13F filing for Q4 2021, filed 14 Feb 2022.